Skip to main content
Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 3, Number 6, December 2003

Review article

Hypoxia Inducible Factor as a Cancer Drug Target
pp. 391-405(15)
Authors: Welsh, Sarah J.; Powis, Garth


Nitric Oxide-Releasing Non Steroidal Anti-Inflammatory Drugs: A New Generation of Anti-Tumoral Molecules
pp. 407-426(20)
Authors: Lavagna, Christian; Soldato, Piero D.; Burgaud, Jean-Luc; Rampal, Patrick


Emerging Role of Endoglin (CD105) as a Marker of Angiogenesis with Clinical Potential in Human Malignancies
pp. 427-432(6)
Authors: Fonsatti, E.; Sigalotti, L.; Arslan, P.; Altomonte, M.; Maio, M.


Thomsen-Friedenreich Disaccharide Immunogenicity
pp. 433-443(11)
Authors: Irazoqui, Fernando J.; Nores, Gustavo A.


Metabolic Biomarker and Kinase Drug Target Discovery in Cancer Using Stable Isotope-Based Dynamic Metabolic Profiling (SIDMAP)
pp. 445-453(9)
Authors: Boros, Laszlo G.; Brackett, Daniel J.; Harrigan, George G.


  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more